BRIEF published on 04/25/2025 at 15:44, 11 months ago Pentixapharm to Showcase Innovative Antibody GT-008 at AACR 2025 Cancer Therapy Pentixapharm GT-008 Antibody Glycan-Dependent CD24 Targeting
PRESS RELEASE published on 04/25/2025 at 15:39, 11 months ago Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 Pentixapharm to present novel CD24 antibody GT-008 for solid tumors at AACR 2025, showcasing glycan-dependent mechanism for targeted therapy Solid Tumors Pentixapharm AACR 2025 GT-008 CD24 Antibody
BRIEF published on 04/24/2025 at 14:05, 11 months 1 day ago Pentixapharm signe un accord de fabrication pour la thérapie à l'yttrium-90 Eckert & Ziegler Essais Cliniques Produits Radiopharmaceutiques Pentixapharm Yttrium-90
BRIEF published on 04/24/2025 at 14:05, 11 months 1 day ago Pentixapharm Signs Manufacturing Deal for Yttrium-90 Therapy Clinical Trials Eckert & Ziegler Radiopharmaceuticals Pentixapharm Yttrium-90
PRESS RELEASE published on 04/24/2025 at 14:00, 11 months 1 day ago Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE Pentixapharm signs manufacturing agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE to produce CXCR4-targeting radiotherapeutic doses for clinical trials Clinical Trials Eckert & Ziegler SE Pentixapharm Y90-PentixaTher Radiotherapeutic
BRIEF published on 04/15/2025 at 08:22, 11 months 11 days ago Pentixapharm Holding AG publie ses résultats financiers pour 2024 et ses perspectives pour 2025 Recherche Et Développement Résultats Financiers 2024 Prévisions Financières 2025 Innovation Radiopharmaceutique Stratégie Pentixapharm
BRIEF published on 04/15/2025 at 08:22, 11 months 11 days ago Pentixapharm Holding AG Reports 2024 Financial Results and 2025 Outlook Research And Development Financial Results 2024 2025 Financial Forecast Radiopharmaceutical Innovation Pentixapharm Strategy
PRESS RELEASE published on 04/15/2025 at 08:17, 11 months 11 days ago Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guidance for the 2025 Financial Year Pentixapharm Holding AG releases 2024 financial results with EUR 12.8 million net loss and guides for EUR 23.5 million loss in 2025, focusing on R&D and operating expenses Financial Results 2024 Net Loss 2025 Pentixapharm
BRIEF published on 03/03/2025 at 14:43, 1 year ago Pentixapharm Holding AG Announces Board Changes Supervisory Board Board Changes Leadership Transition Pentixapharm Governance Dr. Andreas Eckert
BRIEF published on 03/03/2025 at 14:43, 1 year ago Pentixapharm Holding AG annonce des changements au sein de son conseil d'administration Conseil De Surveillance Transition De Direction Changements Au Sein Du Conseil D'administration Dr. Andreas Eckert Gouvernance De Pentixapharm
Published on 03/26/2026 at 12:05, 21 minutes ago Aton Reports the First Results from its Abu Marawat RC Infill Drill Programme, Including 17.13 g/t Gold, 307 g/t Silver, 0.82% Copper and 5.50% Zinc Over a 9 Metre Interval
Published on 03/26/2026 at 12:00, 26 minutes ago EV Nickel Reports New Gold Discovery At Gemini North Nickel Zone
Published on 03/26/2026 at 11:07, 1 hour 19 minutes ago U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal
Published on 03/26/2026 at 11:00, 1 hour 26 minutes ago Pivotree Announces Fourth Quarter 2025 Results
Published on 03/26/2026 at 12:17, 8 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 03/26/2026 at 12:05, 21 minutes ago Artlist Expands Its AI Platform with Professional-Grade AI Music for Video Production
Published on 03/26/2026 at 11:56, 30 minutes ago IVU continues its growth trajectory in the 2025 financial year
Published on 03/26/2026 at 11:03, 1 hour 23 minutes ago EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH
Published on 03/26/2026 at 11:00, 1 hour 26 minutes ago Genel Energy PLC: Posting of Annual Report and Notice of AGM
Published on 03/26/2026 at 07:30, 4 hours 56 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 4 hours 56 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 17 hours 32 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
